BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38836045)

  • 1. Implementation of multifaceted diagnostic stewardship for
    Sasaki Y; Yano M; Umehara A; Tagashira Y
    Antimicrob Steward Healthc Epidemiol; 2024; 4(1):e96. PubMed ID: 38836045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Clostridioides difficile Diagnostic Stewardship Interventions on the Diagnosis of Hospital-Onset Clostridioides difficile Infections.
    Kang M; Abeles SR; El-Kareh R; Taplitz RA; Nyheim E; Reed SL; Jenkins IH; Seymann GB; Myers FE; Torriani FJ;
    Jt Comm J Qual Patient Saf; 2020 Aug; 46(8):457-463. PubMed ID: 32576438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic stewardship of C. difficile testing: a quasi-experimental antimicrobial stewardship study.
    Christensen AB; Barr VO; Martin DW; Anderson MM; Gibson AK; Hoff BM; Sutton SH; Widmaier V; Salim AA; Silkaitis C; Qi C; Zembower TR; Postelnick MJ; Rhodes NJ
    Infect Control Hosp Epidemiol; 2019 Mar; 40(3):269-275. PubMed ID: 30786942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using diagnostic stewardship to reduce rates, healthcare expenditures and accurately identify cases of hospital-onset
    Solanky D; Juang DK; Johns ST; Drobish IC; Mehta SR; Kumaraswamy M
    Infect Control Hosp Epidemiol; 2021 Jan; 42(1):51-56. PubMed ID: 32943129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the COVID-19 pandemic on the incidence of healthcare facility-onset Clostridioides difficile infection in hospitalized patients with sepsis: Interrupted time series analysis using Japanese Diagnosis Procedure Combination data.
    Endo K; Mizuno K; Takeuchi M; Kawakami K
    Anaerobe; 2023 Feb; 79():102693. PubMed ID: 36623703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDC's Hospital-Onset Clostridioides difficile Prevention Framework in a Regional Hospital Network.
    Turner NA; Krishnan J; Nelson A; Polage CR; Sinkowitz-Cochran RL; Fike L; Kuhar DT; Kutty PK; Snyder RL; Anderson DJ
    JAMA Netw Open; 2024 Mar; 7(3):e243846. PubMed ID: 38536174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase of healthcare-onset Clostridioides difficile infection in adult population since SARS-CoV-2 pandemic: A retrospective cohort study in a tertiary care hospital from 2019 to 2022.
    Maldonado-Barrueco A; Moreno-Ramos F; Díaz-Pollán B; Loeches-Yagüe B; Rico-Nieto A; García-Rodríguez J; Ruiz-Carrascoso G
    Anaerobe; 2024 Apr; 86():102836. PubMed ID: 38428802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clostridioides (Clostridium) difficile infection burden in Japan: A multicenter prospective study.
    Kato H; Senoh M; Honda H; Fukuda T; Tagashira Y; Horiuchi H; Chiba H; Suzuki D; Hosokawa N; Kitazono H; Norisue Y; Kume H; Mori N; Morikawa H; Kashiwagura S; Higuchi A; Kato H; Nakamura M; Ishiguro S; Morita S; Ishikawa H; Watanabe T; Kojima K; Yokomaku I; Bando T; Toimoto K; Moriya K; Kasahara K; Kitada S; Ogawa J; Saito H; Tominaga H; Shimizu Y; Masumoto F; Tadera K; Yoshida J; Kikuchi T; Yoshikawa I; Watanabe T; Honda M; Yokote K; Toyokawa T; Miyazato H; Nakama M; Mahe C; Reske K; Olsen MA; Dubberke ER
    Anaerobe; 2019 Dec; 60():102011. PubMed ID: 30872073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction in Health Care Facility-Onset
    Zaver HB; Moktan VP; Harper EP; Bali A; Nasir A; Foulks C; Kuhlman J; Green M; Algan GA; Parth HC; Wu-Ballis M; DiCicco S; Smith BT; Owen RN; Mai LS; Spiros SL; Griffis J; Ramsey Walker DT; Hata DJ; Oring JM; Powers HR; Bosch W
    Mayo Clin Proc Innov Qual Outcomes; 2021 Dec; 5(6):1066-1074. PubMed ID: 34820598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of consolidated framework for implementation research to improve Clostridioides difficile infection management in district hospitals.
    Legenza L; Coetzee R; Rose WE; Esack T; Crombie K; Mina M; Safdar N; Barnett SG
    Res Social Adm Pharm; 2022 Dec; 18(12):4100-4111. PubMed ID: 35981939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reductions in inpatient fluoroquinolone use and postdischarge
    Jones KA; Onwubiko UN; Kubes J; Albrecht B; Paciullo K; Howard-Anderson J; Suchindran S; Trible R; Jacob JT; Yi SH; Goodenough D; Fridkin SK; Sexton ME; Wiley Z
    Antimicrob Steward Healthc Epidemiol; 2021; 1(1):e32. PubMed ID: 36168449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Mandatory Infectious Disease Specialist Approval on Hospital-Onset Clostridioides difficile Infection Rates and Testing Appropriateness.
    Lin MY; Stein BD; Kothadia SM; Blank S; Schoeny ME; Tomich A; Hayden MK; Segreti J
    Clin Infect Dis; 2023 Aug; 77(3):346-350. PubMed ID: 37157903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Burden of Clostridioides Difficile Infection during the COVID-19 Pandemic: A Retrospective Case-Control Study in Italian Hospitals (CloVid).
    Granata G; Bartoloni A; Codeluppi M; Contadini I; Cristini F; Fantoni M; Ferraresi A; Fornabaio C; Grasselli S; Lagi F; Masucci L; Puoti M; Raimondi A; Taddei E; Trapani FF; Viale P; Johnson S; Petrosillo N; On Behalf Of The CloVid Study Group
    J Clin Med; 2020 Nov; 9(12):. PubMed ID: 33260943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of Clinical Decision Support Alerts on Clostridioides difficile Testing: A Systematic Review.
    Dunn AN; Radakovich N; Ancker JS; Donskey CJ; Deshpande A
    Clin Infect Dis; 2021 Mar; 72(6):987-994. PubMed ID: 32060501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of a Structured Process for Clinically Indicated Testing for
    Kusma M; Little J; Kociolek L
    J Pediatr Hematol Oncol Nurs; 2023; 40(3):188-194. PubMed ID: 36691391
    [No Abstract]   [Full Text] [Related]  

  • 16. Burden of Clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI.
    Finn E; Andersson FL; Madin-Warburton M
    BMC Infect Dis; 2021 May; 21(1):456. PubMed ID: 34016040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical impact of a pharmacist-led antimicrobial stewardship initiative evaluating patients with
    Bishop PA; Isache C; McCarter YS; Smotherman C; Gautam S; Jankowski CA
    J Investig Med; 2020 Apr; 68(4):888-892. PubMed ID: 32066570
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of the COVID-19 Pandemic on Rates and Epidemiology of
    Wright LM; Skinner AM; Cheknis A; McBurney C; Ge L; Pacheco SM; Leehey D; Gerding DN; Johnson S
    Antibiotics (Basel); 2023 Jul; 12(7):. PubMed ID: 37508255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Community Factors with Hospital-onset
    Zacharioudakis IM; Zervou FN; Shehadeh F; Mylona EK; Mylonakis E
    EClinicalMedicine; 2019 Feb; 8():12-19. PubMed ID: 31193719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal trends of inpatient
    Sumon ZE; Lesse AJ; Sellick JA; Tetewsky S; Mergenhagen KA
    Infect Control Hosp Epidemiol; 2020 Jan; 41(1):44-51. PubMed ID: 31708000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.